Ayala Pharmaceuticals Inc (ADXS)

[samk]

Zoltarak, I would add the following event that will have a positive effect on a stock price before the EU approval:

ADXS-NEO trial (or first patient dosing) announcement with a milestone payment.
ADXS-PSA combo positive results at ASCO. Could also expect a licensing agreement with Merck.

And we have no knowledge what else could happen, including other licensing deals.